These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Extracellular vesicles for drug delivery. Vader P; Mol EA; Pasterkamp G; Schiffelers RM Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656 [TBL] [Abstract][Full Text] [Related]
5. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements. Huyan T; Li H; Peng H; Chen J; Yang R; Zhang W; Li Q Int J Nanomedicine; 2020; 15():6485-6502. PubMed ID: 32922012 [TBL] [Abstract][Full Text] [Related]
6. Extracellular Vesicles as Natural Nanosized Delivery Systems for Small-Molecule Drugs and Genetic Material: Steps towards the Future Nanomedicines. Kotmakçı M; Bozok Çetintaş V J Pharm Pharm Sci; 2015; 18(3):396-413. PubMed ID: 26517135 [TBL] [Abstract][Full Text] [Related]
7. Drug Delivery with Extracellular Vesicles: From Imagination to Innovation. de Jong OG; Kooijmans SAA; Murphy DE; Jiang L; Evers MJW; Sluijter JPG; Vader P; Schiffelers RM Acc Chem Res; 2019 Jul; 52(7):1761-1770. PubMed ID: 31181910 [TBL] [Abstract][Full Text] [Related]
8. Self-Assembly of Extracellular Vesicle-like Metal-Organic Framework Nanoparticles for Protection and Intracellular Delivery of Biofunctional Proteins. Cheng G; Li W; Ha L; Han X; Hao S; Wan Y; Wang Z; Dong F; Zou X; Mao Y; Zheng SY J Am Chem Soc; 2018 Jun; 140(23):7282-7291. PubMed ID: 29809001 [TBL] [Abstract][Full Text] [Related]
9. Systematic Review of Cancer Targeting by Nanoparticles Revealed a Global Association between Accumulation in Tumors and Spleen. Drozdov AS; Nikitin PI; Rozenberg JM Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884816 [TBL] [Abstract][Full Text] [Related]
10. Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles. Li A; Zhao Y; Li Y; Jiang L; Gu Y; Liu J Drug Deliv; 2021 Dec; 28(1):1237-1255. PubMed ID: 34142930 [TBL] [Abstract][Full Text] [Related]
11. On the Choice of the Extracellular Vesicles for Therapeutic Purposes. Campanella C; Caruso Bavisotto C; Logozzi M; Marino Gammazza A; Mizzoni D; Cappello F; Fais S Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634425 [TBL] [Abstract][Full Text] [Related]
12. Exosomes: Nanoparticulate tools for RNA interference and drug delivery. Shahabipour F; Barati N; Johnston TP; Derosa G; Maffioli P; Sahebkar A J Cell Physiol; 2017 Jul; 232(7):1660-1668. PubMed ID: 28063231 [TBL] [Abstract][Full Text] [Related]
13. Toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery. Chen C; Wang J; Sun M; Li J; Wang HD Biomed Pharmacother; 2022 Jan; 145():112416. PubMed ID: 34781147 [TBL] [Abstract][Full Text] [Related]
14. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine. Du JZ; Li HJ; Wang J Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728 [TBL] [Abstract][Full Text] [Related]
15. Research Progress in Bioinspired Drug Delivery Systems. Tong Q; Qiu N; Ji J; Ye L; Zhai G Expert Opin Drug Deliv; 2020 Sep; 17(9):1269-1288. PubMed ID: 32543953 [TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicles in Modifying the Effects of Ionizing Radiation. Szatmári T; Hargitai R; Sáfrány G; Lumniczky K Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698689 [TBL] [Abstract][Full Text] [Related]